197 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
BDX Becton, Dickinson and Company $257.23 $68.83B N/A
Article Searches
What's in Store for Cardinal Health's (CAH) Q2 Earnings? http://www.zacks.com/stock/news/351730/whats-in-store-for-cardinal-healths-cah-q2-earnings?cid=CS-ZC-FT-351730 Feb 04, 2019 - Cardinal Health (CAH) likely to gain from solid Pharmaceutical revenues in fiscal Q2; medical-gloves sub-segment likely to be soft.
Why the Earnings Surprise Streak Could Continue for Becton Dickinson (BDX) http://www.zacks.com/stock/news/350732/why-the-earnings-surprise-streak-could-continue-for-becton-dickinson-bdx?cid=CS-ZC-FT-350732 Jan 30, 2019 - Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Becton Dickinson (BDX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release http://www.zacks.com/stock/news/350471/becton-dickinson-bdx-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release?cid=CS-ZC-FT-350471 Jan 29, 2019 - Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CONMED (CNMD) Q4 Earnings Match Estimates, Revenues Beat http://www.zacks.com/stock/news/348903/conmed-cnmd-q4-earnings-match-estimates-revenues-beat?cid=CS-ZC-FT-348903 Jan 23, 2019 - CONMED's (CNMD) Q4 results get a boost from solid segmental performances.
Here's Why Investors Should Bet on Abiomed (ABMD) Stock Now http://www.zacks.com/stock/news/348831/heres-why-investors-should-bet-on-abiomed-abmd-stock-now?cid=CS-ZC-FT-348831 Jan 22, 2019 - Strong contribution from Impella product line is likely to provide Abiomed (ABMD) a competitive edge in the MedTech space.
Zacks.com featured expert Kevin Matras highlights: Caseys General Stores, Becton, Dickinson and Company, ArcBest, Tetra Tech and Nexstar Media http://www.zacks.com/stock/news/348564/zackscom-featured-expert-kevin-matras-highlights-caseys-general-stores-becton-dickinson-and-company-arcbest-tetra-tech-and-nexstar-media?cid=CS-ZC-FT-348564 Jan 21, 2019 - Zacks.com featured expert Kevin Matras highlights: Caseys General Stores, Becton, Dickinson and Company, ArcBest, Tetra Tech and Nexstar Media
Here's Why Investors Should Hold AngioDynamics (ANGO) Now http://www.zacks.com/stock/news/348272/heres-why-investors-should-hold-angiodynamics-ango-now?cid=CS-ZC-FT-348272 Jan 18, 2019 - AngioDynamics' (ANGO) flagship NanoKnife System is currently witnessing robust demand.
Cerner Picked by Remi Vista for Behavioral Health Technology http://www.zacks.com/stock/news/348270/cerner-picked-by-remi-vista-for-behavioral-health-technology?cid=CS-ZC-FT-348270 Jan 18, 2019 - Apart from Cerner Integrated, Cerner's (CERN) revenue cycle solutions will help Remi Vista's financial operations.
Allscripts Selected by Premier for Connected Health Platform http://www.zacks.com/stock/news/347954/allscripts-selected-by-premier-for-connected-health-platform?cid=CS-ZC-FT-347954 Jan 17, 2019 - Premier Orthopaedics will leverage on Allscripts' (MDRX) Professional EHR, Practice Management software, FollowMyHealth and Payerpath suite of solutions.
Here's Why You Should Invest in OPKO Health (OPK) Right Now http://www.zacks.com/stock/news/347638/heres-why-you-should-invest-in-opko-health-opk-right-now?cid=CS-ZC-FT-347638 Jan 16, 2019 - OPKO Health's (OPK) flagship RAYALDEE lends it a competitive edge in the MedTech space.

Pages: 12345678...20

<<<Page 3>